Clinical Trial Update: Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update describes a Phase 2 pediatric trial comparing chemotherapy regimens for relapsed or progressive rhabdomyosarcoma in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Rhabdomyosarcoma
• Botryoid Rhabdomyosarcoma
• Embryonal Rhabdomyosarcoma
• Rhabdomyosarcoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma | Phase 2 | Status: COMPLETED